Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease
Study of 269 patients enrolled in ARISTOTLE found that among patients with AF and CrCl 25-30 mL/min, apixaban caused less major bleeding than warfarin (HR 0.34, 95% CI, 0.14-0.80) and major or clinically relevant non-major bleeding (HR 0.35, 95% CI 0.17-0.72)
Source:
Circulation